Market Highlights
Global Veterinary Medicine Market is likely to register a CAGR of 5.57% during the forecast period and expected to hit USD 42,985.42 Million by 2027.
Like humans, animals are prone to various diseases caused by bacteria, parasites, fungi, and viruses. Veterinary medicine is one of the most effective ways to reduce the disease burden in farm animals and pets. Increasing zoonotic and chronic diseases among animals affect human interests widely. One of the main reasons for the growing number of chronic diseases is the increasing life expectancy of pets due to the developing healthcare facilities and good nutrition.
The growing rates of pet ownership, rising chronic diseases, and increasing consumption of meat are anticipated to drive the growth of the global veterinary medicine market. Recently, in November 2018, Merck Animal Health launched new vaccine INNOVAX-ND-IBD in the US. This vaccine is mainly used for treatment of highly infectious diseases such as infectious bursal disease and new castle disease. Moreover, in July 2019, Vetoquinol S.A. announced a plan to reorganize its production facilities in Europe. Under the agreement, the company will hand over the production of the Ascor range, currently manufactured at the Vetoquinol Italia plant in Emilia-Romagna, to pharmaceutical facilities in Europe. The Ascor range includes veterinary drugs and non-medicinal products primarily designed for pig and poultry farmers.
Segment Analysis
Global Veterinary Medicine Market has been divided based on Animal Type, Product, Route of Administration, and Distribution Channel.
The market, based on animal type, has been segregated into domesticated and companion. Based on product, the global veterinary medicine market is segmented into drugs and vaccines. The global veterinary medicine market, on the basis of route of administration, has been segmented into oral, parental, and others. On the basis of distribution channel, the market is bifurcated into veterinary hospitals & clinics, retail stores, and online pharmacies.
Regional Analysis
Global Veterinary Medicine Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa. The Americas is likely to hold the largest share of the global veterinary medicine market during the assessment period owing to the rise in companion animal ownership and growing prevalence of animal diseases in the region. The Europe market is expected to register a substantial growth in the market owing to the rising prevalence of diseases, new product approvals, and presence of developed veterinary healthcare infrastructure. Asia-Pacific is estimated to be the fastest-growing regional market due to the growing penetration of the veterinary sector, surge in the number of private veterinary clinics, increasing awareness about animal welfare, and government campaigns for the welfare of pet animals in China, Japan, India, South Korea, and Australia. The veterinary medicine market in Middle East & Africa is expected to witness gradual growth owing to the presence of low-income countries in the region.
Access Report Details @ https://www.marketresearchfuture.com/reports/veterinary-medicine-market-844
Key Players
MRFR recognizes the following companies as the Key Players in the global Veterinary Medicine Market— Boehringer Ingelheim, Ceva, Chanelle Pharma Group, Dechra Pharmaceuticals plc, Elanco, Merck Animal Health, Norbrook Laboratories, Vetoquinol S.A., Bayer AG, and Zoetis.
Key Findings of the Study
- Global Veterinary Medicine Market was valued at USD 28,012.73 Million in 2019 and is expected to register a CAGR of 5.57% during the assessment period
- The Americas accounted for the largest share of the global market due to the rise in companion animal ownership and growing prevalence of animal diseases in the region
- Based on animal type, the companion segment is expected to register the fastest growth at a CAGR of 6.04% during the forecast period
- On the basis of the product, the drugs segment accounted for the largest market share with a value of USD 17,604.08 million in 2019
- Based on route of administration, the oral segment accounted for the largest market share with 50.6% in 2019
- Based on the distribution channel, the veterinary hospitals & clinics segment accounted for the largest market share with a value of USD 31,196.57 million in 2027
No comments:
Post a Comment